| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9979460 | The Journal of Thoracic and Cardiovascular Surgery | 2005 | 7 Pages |
Abstract
Patients with large cell neuroendocrine carcinomas have a significantly worse survival after resection than patients with large cell carcinomas, even in stage I disease. Accurate differentiation of large cell neuroendocrine carcinoma from large cell carcinoma is important because it identifies those patients at highest risk for the development of recurrent lung cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Richard J. MD, PhD, Felix G. MD, John MD, Bryan F. MD, Tracey J. RN, Joel D. MD, G. Alexander MD,